Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1994 May;78(5):365–369. doi: 10.1136/bjo.78.5.365

A double blind placebo controlled group comparative study of ophthalmic sodium cromoglycate and nedocromil sodium in the treatment of vernal keratoconjunctivitis.

M el Hennawi 1
PMCID: PMC504789  PMID: 8025071

Abstract

In a 4 week double masked comparative study, patients received 2% nedocromil sodium (48), 2% sodium cromoglycate (48), or placebo eye drops (42), four times daily, for the treatment of vernal keratoconjunctivitis (VKC). Clinical examinations of eye condition and symptom severity were made before and after a 1 week baseline before starting test treatment, and after 1, 2, and 4 weeks of treatment. Patients kept daily diary card records of symptom severity and concomitant therapy. At the clinic, significant improvements were seen with both active treatments after 2-4 weeks. During the final visit, significant benefits over placebo were recorded for five ocular signs with nedocromil sodium and three with sodium cromoglycate, bulbar and lower tarsal chemosis being better controlled by nedocromil sodium (p < 0.05 v sodium cromoglycate). Diary card trends showed improvement with all three treatments, which was greatest with nedocromil sodium and least with placebo. Compared with placebo, both the active drugs produced statistically significant improvements in general eye condition during weeks 1-2, and nedocromil sodium significantly reduced itching within the first week. Overall, nedocromil sodium had the greatest effect on symptoms, although diary card data revealed no statistically significant differences between the two active drugs. In conclusion, both 2% nedocromil sodium and 2% sodium cromoglycate were effective in controlling VKC when administered four times daily into the eyes, while the marked anti-inflammatory activity of nedocromil sodium was apparent in its more pronounced overall therapeutic effect.

Full text

PDF
365

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abelson M. B., George M. A., Garofalo C. Differential diagnosis of ocular allergic disorders. Ann Allergy. 1993 Feb;70(2):95–109. [PubMed] [Google Scholar]
  2. Allansmith M. R., Ross R. N. Ocular allergy and mast cell stabilizers. Surv Ophthalmol. 1986 Jan-Feb;30(4):229–244. doi: 10.1016/0039-6257(86)90119-0. [DOI] [PubMed] [Google Scholar]
  3. Allansmith M. R., Ross R. N. Ocular allergy. Clin Allergy. 1988 Jan;18(1):1–13. doi: 10.1111/j.1365-2222.1988.tb02837.x. [DOI] [PubMed] [Google Scholar]
  4. Bonini S., Barney N. P., Schiavone M., Centofanti M., Berruto A., Bonini S., Allansmith M. R. Effectiveness of nedocromil sodium 2% eyedrops on clinical symptoms and tear fluid cytology of patients with vernal conjunctivitis. Eye (Lond) 1992;6(Pt 6):648–652. doi: 10.1038/eye.1992.139. [DOI] [PubMed] [Google Scholar]
  5. Brogden R. N., Sorkin E. M. Nedocromil sodium. An updated review of its pharmacological properties and therapeutic efficacy in asthma. Drugs. 1993 May;45(5):693–715. doi: 10.2165/00003495-199345050-00007. [DOI] [PubMed] [Google Scholar]
  6. Ciprandi G., Buscaglia S., Cerqueti P. M., Canonica G. W. Drug treatment of allergic conjunctivitis. A review of the evidence. Drugs. 1992 Feb;43(2):154–176. doi: 10.2165/00003495-199243020-00003. [DOI] [PubMed] [Google Scholar]
  7. Ehlers W. H., Donshik P. C. Allergic ocular disorders: a spectrum of diseases. CLAO J. 1992 Apr;18(2):117–124. [PubMed] [Google Scholar]
  8. El Hennawi M. A comparison between 2% and 4% sodium cromoglycate eye drops in the treatment of vernal keratoconjunctivitis. Curr Eye Res. 1982;2(11):765–768. doi: 10.3109/02713688209020009. [DOI] [PubMed] [Google Scholar]
  9. El Hennawi M. Clinical trial with 2% sodium cromoglycate (Opticrom) in vernal keratoconjunctivitis. Br J Ophthalmol. 1980 Jul;64(7):483–486. doi: 10.1136/bjo.64.7.483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Irani A. M., Butrus S. I., Tabbara K. F., Schwartz L. B. Human conjunctival mast cells: distribution of MCT and MCTC in vernal conjunctivitis and giant papillary conjunctivitis. J Allergy Clin Immunol. 1990 Jul;86(1):34–40. doi: 10.1016/s0091-6749(05)80120-4. [DOI] [PubMed] [Google Scholar]
  11. Kay A. B., Walsh G. M., Moqbel R., MacDonald A. J., Nagakura T., Carroll M. P., Richerson H. B. Disodium cromoglycate inhibits activation of human inflammatory cells in vitro. J Allergy Clin Immunol. 1987 Jul;80(1):1–8. doi: 10.1016/s0091-6749(87)80183-5. [DOI] [PubMed] [Google Scholar]
  12. Leino M., Ennevaara K., Latvala A. L., Nordgren P., Posti A. M., Suves R., Takalo E. Double-blind group comparative study of 2% nedocromil sodium eye drops with 2% sodium cromoglycate and placebo eye drops in the treatment of seasonal allergic conjunctivitis. Clin Exp Allergy. 1992 Oct;22(10):929–932. doi: 10.1111/j.1365-2222.1992.tb02066.x. [DOI] [PubMed] [Google Scholar]
  13. Moqbel R., Cromwell O., Walsh G. M., Wardlaw A. J., Kurlak L., Kay A. B. Effects of nedocromil sodium (Tilade) on the activation of human eosinophils and neutrophils and the release of histamine from mast cells. Allergy. 1988 May;43(4):268–276. doi: 10.1111/j.1398-9995.1988.tb00899.x. [DOI] [PubMed] [Google Scholar]
  14. Romagnani S., Maggi E., Parronchi P., Macchia D., Piccinni M. P., Ricci M. Increased numbers of Th2-like CD4+ T cells in target organs and in the allergen-specific repertoire of allergic patients. Possible role of IL-4 produced by non-T cells. Int Arch Allergy Appl Immunol. 1991;94(1-4):133–136. doi: 10.1159/000235344. [DOI] [PubMed] [Google Scholar]
  15. Schuller D. E., Selcow J. E., Joos T. H., Hannaway P. J., Hirsch S. R., Schwartz H. J., Filley W. V., Fink J. N. A multicenter trial of nedocromil sodium, 1% nasal solution, compared with cromolyn sodium and placebo in ragweed seasonal allergic rhinitis. J Allergy Clin Immunol. 1990 Oct;86(4 Pt 1):554–561. doi: 10.1016/s0091-6749(05)80212-x. [DOI] [PubMed] [Google Scholar]
  16. Sorkin E. M., Ward A. Ocular sodium cromoglycate. An overview of its therapeutic efficacy in allergic eye disease. Drugs. 1986 Feb;31(2):131–148. doi: 10.2165/00003495-198631020-00003. [DOI] [PubMed] [Google Scholar]
  17. Urban R. C., Jr, Cotlier E. Corticosteroid-induced cataracts. Surv Ophthalmol. 1986 Sep-Oct;31(2):102–110. doi: 10.1016/0039-6257(86)90077-9. [DOI] [PubMed] [Google Scholar]
  18. Vakil D. V., Ayiomamitis A., Nizami R. M. Treatment of seasonal conjunctivitis: comparison of 2% and 4% sodium cromoglycate ophthalmic solutions. Can J Ophthalmol. 1984 Aug;19(5):207–211. [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES